Publisher
Springer International Publishing
Reference87 articles.
1. NCI Dictionary of Cancer Terms. https://www.cancer.gov/publications/dictionaries/cancer-terms.
2. Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, Kuroi K, Im SA, Park BW, Kim SB, Yanagita Y, Ohno S, Takao S, Aogi K, Iwata H, Jeong J, Kim A, Park KH, Sasano H, Ohashi Y, Toi M. Adjuvant Capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376:2147–59. https://doi.org/10.1056/NEJMoa1612645.
3. NCCN breast cancer guidelines, v4.2020. https://www.nccn.org/guidelines/category_1.
4. Sherry AD, Mayer IA, Ayala-Peacock DN, Abramson VG, Rexer BN, Chakravarthy AB. Combining adjuvant radiotherapy with Capecitabine in chemotherapy-resistant breast cancer: feasibility, safety, and toxicity. Clin Breast Cancer. 2020 Aug;20(4):344–52. https://doi.org/10.1016/j.clbc.2020.02.010.
5. Liu YL, Chin C, Catanese B, Lee SM, Zhan S, Kalinsky K, Connolly EP. Concurrent use of capecitabine with radiation therapy and survival in breast cancer (BC) after neoadjuvant chemotherapy. Clin Transl Oncol. 2018;20(10):1280–8. https://doi.org/10.1007/s12094-018-1859-7.